{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:26:27Z","timestamp":1792794387736,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"23","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"British Heart Foundation Intermediate Fellowship","award":["FS\/15\/8\/3115"],"award-info":[{"award-number":["FS\/15\/8\/3115"]}],"id":[{"id":"https:\/\/ror.org\/02wdwnk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Oxford Health Services Research","award":["OHSRC: 1135"],"award-info":[{"award-number":["OHSRC: 1135"]}]},{"name":"BHF Clinical Research Fellowship"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL125730"],"award-info":[{"award-number":["HL125730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2HL142045"],"award-info":[{"award-number":["DP2HL142045"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL084261"],"award-info":[{"award-number":["HL084261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OT2OD023848"],"award-info":[{"award-number":["OT2OD023848"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BHF Centre of Research Excellence","award":["RE\/08\/004"],"award-info":[{"award-number":["RE\/08\/004"]}]},{"name":"Oxford National Institute for Health Research","id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>ST-elevation myocardial infarction is associated with high levels of cardiac sympathetic drive and release of the co-transmitter neuropeptide Y (NPY). We hypothesized that despite beta-blockade, NPY promotes arrhythmogenesis via ventricular myocyte receptors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In 78 patients treated with primary percutaneous coronary intervention, sustained ventricular tachycardia (VT) or fibrillation (VF) occurred in 6 (7.7%) within 48\u2009h. These patients had significantly (P\u2009&amp;lt;\u20090.05) higher venous NPY levels despite the absence of classical risk factors including late presentation, larger infarct size, and beta-blocker usage. Receiver operating curve identified an NPY threshold of 27.3\u2009pg\/mL with a sensitivity of 0.83 and a specificity of 0.71. RT-qPCR demonstrated the presence of NPY mRNA in both human and rat stellate ganglia. In the isolated Langendorff perfused rat heart, prolonged (10\u2009Hz, 2\u2009min) stimulation of the stellate ganglia caused significant NPY release. Despite maximal beta-blockade with metoprolol (10\u2009\u03bcmol\/L), optical mapping of ventricular voltage and calcium (using RH237 and Rhod2) demonstrated an increase in magnitude and shortening in duration of the calcium transient and a significant lowering of ventricular fibrillation threshold. These effects were prevented by the Y1 receptor antagonist BIBO3304 (1\u2009\u03bcmol\/L). Neuropeptide Y (250\u2009nmol\/L) significantly increased the incidence of VT\/VF (60% vs. 10%) during experimental ST-elevation ischaemia and reperfusion compared to control, and this could also be prevented by BIBO3304.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The co-transmitter NPY is released during sympathetic stimulation and acts as a novel arrhythmic trigger. Drugs inhibiting the Y1 receptor work synergistically with beta-blockade as a new anti-arrhythmic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehz852","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T15:10:27Z","timestamp":1573571427000},"page":"2168-2179","source":"Crossref","is-referenced-by-count":107,"title":["The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade"],"prefix":"10.1093","volume":"41","author":[{"given":"Manish","family":"Kalla","sequence":"first","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"},{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidi","family":"Tapoulal","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tomek","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Woodward","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"\u2018Oxford Acute Myocardial Infarction (OxAMI) Study\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2165-7154","authenticated-orcid":false,"given":"Erica","family":"Dall\u2019Armellina","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian P","family":"Banning","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"},{"name":"Radcliffe Department of Medicine, Acute Vascular Imaging Centre, University of Oxford , Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh K","family":"Kharbanda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-4342","authenticated-orcid":false,"given":"Keith M","family":"Channon","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olujimi A","family":"Ajijola","sequence":"additional","affiliation":[{"name":"UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center , Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-1766","authenticated-orcid":false,"given":"Kalyanam","family":"Shivkumar","sequence":"additional","affiliation":[{"name":"UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center , Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-3256","authenticated-orcid":false,"given":"David J","family":"Paterson","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-6133","authenticated-orcid":false,"given":"Neil","family":"Herring","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, University of Oxford , Parks Road, Oxford OX13PT, UK"},{"name":"Department of Cardiovascular Medicine, John Radcliffe Hospital , University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"2022102611454940400_ehz852-B1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1152\/ajplegacy.1969.217.3.703","article-title":"A sympathetic reflex elicited by experimental coronary occlusion","volume":"217","author":"Malliani","year":"1969","journal-title":"Am J Physiol"},{"key":"2022102611454940400_ehz852-B2","doi-asserted-by":"crossref","first-page":"760.","DOI":"10.1038\/s41569-019-0297-8","article-title":"The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies","volume":"16","author":"Herring","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2022102611454940400_ehz852-B3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrcardio.2014.19","article-title":"Cardiac sympathetic denervation to prevent life-threatening arrhythmias","volume":"11","author":"Schwartz","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2022102611454940400_ehz852-B4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102611454940400_ehz852-B5","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"2022102611454940400_ehz852-B6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.yjmcc.2011.11.016","article-title":"The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability","volume":"52","author":"Herring","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"2022102611454940400_ehz852-B7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3940(89)90344-3","article-title":"Changes in cardiac neuropeptide Y after experimental myocardial infarction in rat","volume":"104","author":"Han","year":"1989","journal-title":"Neurosci Lett"},{"key":"2022102611454940400_ehz852-B8","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/eurheartj\/ehz115","article-title":"Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction","volume":"40","author":"Herring","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102611454940400_ehz852-B9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/heartjnl-2012-303443","article-title":"Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction","volume":"99","author":"Cuculi","year":"2013","journal-title":"Heart"},{"key":"2022102611454940400_ehz852-B10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front Physiol"},{"key":"2022102611454940400_ehz852-B11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2004.11.001","article-title":"Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation","volume":"38","author":"Heredia","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2022102611454940400_ehz852-B12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.bjp.0704643","article-title":"Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes","volume":"135","author":"Heredia","year":"2002","journal-title":"Br J Pharmacol"},{"key":"2022102611454940400_ehz852-B13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1476-5381.1996.tb15560.x","article-title":"Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes","volume":"118","author":"Bryant","year":"1996","journal-title":"Br J Pharmacol"},{"key":"2022102611454940400_ehz852-B14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/europace\/euu208","article-title":"Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force","volume":"16","author":"Gorenek","year":"2014","journal-title":"Europace"},{"key":"2022102611454940400_ehz852-B15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yjmcc.2007.10.001","article-title":"Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway","volume":"44","author":"Herring","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"2022102611454940400_ehz852-B16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-1838(98)00169-6","article-title":"Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat","volume":"75","author":"Smith-White","year":"1999","journal-title":"J Auton Nerv Syst"},{"key":"2022102611454940400_ehz852-B17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.npep.2004.12.006","article-title":"Galanin modulates cholinergic neurotransmission in the heart","volume":"39","author":"Potter","year":"2005","journal-title":"Neuropeptides"},{"key":"2022102611454940400_ehz852-B18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.hrthm.2015.01.045","article-title":"Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: neuropeptide and morphologic changes","volume":"12","author":"Ajijola","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022102611454940400_ehz852-B19","first-page":"225","article-title":"[Effects of neuropeptide Y on ion channels in ventricular myocytes]","volume":"58","author":"Zhao","year":"2006","journal-title":"Sheng Li Xue Bao"},{"key":"2022102611454940400_ehz852-B20","first-page":"H1727","article-title":"Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes","volume":"261","author":"Millar","year":"1991","journal-title":"Am J Physiol"},{"key":"2022102611454940400_ehz852-B21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1152\/physrev.1999.79.3.917","article-title":"Cardiac ionic currents and acute ischemia: from channels to arrhythmias","volume":"79","author":"Carmeliet","year":"1999","journal-title":"Physiol Rev"},{"key":"2022102611454940400_ehz852-B22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/hh1101.091193","article-title":"Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness","volume":"88","author":"Pogwizd","year":"2001","journal-title":"Circ Res"},{"key":"2022102611454940400_ehz852-B23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/1440-1681.12301","article-title":"Ca(2+)\/calmodulin dependent kinase II: a critical mediator in determining reperfusion outcomes in the heart?","volume":"41","author":"Bell","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2022102611454940400_ehz852-B24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/01.RES.69.2.455","article-title":"Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart","volume":"69","author":"Warner","year":"1991","journal-title":"Circ Res"},{"key":"2022102611454940400_ehz852-B25","doi-asserted-by":"crossref","first-page":"H980","DOI":"10.1152\/ajpheart.00255.2013","article-title":"Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat","volume":"305","author":"Shanks","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022102611454940400_ehz852-B26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/oxfordjournals.eurheartj.a060526","article-title":"Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction","volume":"15","author":"Ullman","year":"1994","journal-title":"Eur Heart J"},{"key":"2022102611454940400_ehz852-B27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/24.2.102","article-title":"Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure","volume":"24","author":"Hulting","year":"1990","journal-title":"Cardiovasc Res"},{"key":"2022102611454940400_ehz852-B28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/jcem-68-4-808","article-title":"Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors","volume":"68","author":"Grouzmann","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102611454940400_ehz852-B29","article-title":"Coronary sinus neuropeptide-Y levels predict adverse outcomes in patients with stable chronic heart failure","author":"Ajijola","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022102611454940400_ehz852-B30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/europace\/euz163","article-title":"Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)","volume":"21","author":"Kalarus","year":"2019","journal-title":"Europace"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/23\/2168\/46643509\/ehz852.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/23\/2168\/46643509\/ehz852.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:47:07Z","timestamp":1666770427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/23\/2168\/5675548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":30,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019,12,13]]},"published-print":{"date-parts":[[2020,6,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz852","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,14]]},"published":{"date-parts":[[2019,12,13]]}}}